A new dataset for predicting antigen-antibody interactions, published in the prestigious machine learning conference NeurIPS 2023, will help accelerate AI drug discovery KYOTO, Japan--(BUSINESS WIRE)- ...
In a recent study published in Nature Machine Intelligence, a team of researchers used a deep antibody-antigen interaction (DeepAAI) algorithm to understand the antibody representations of unseen ...
KYOTO, Japan--(BUSINESS WIRE)--A joint research paper on artificial intelligence (AI)-driven drug discovery by “SAKURA internet Research Center,” an in-house research institute of SAKURA internet Inc.
Antibodies represent the fastest growing class of drugs in the market today, with over 60 antibody drugs currently approved for use and more than 550 in clinical development 1. They are highly ...
The modular nature of antibodies allows the design of antibody-related formats with tailored characteristics. The antibody’s Fc part, encompassing the effector functions, represents an attractive ...
As a basic description, an antibody can be described as any molecule that has epitopes (antigenic sites) that fit with corresponding antibodies, initiating an immune response. Antigens come in many ...
AUTOIMMUNIZATION to autogenously released thyroglobulin has recently been implicated as a causative factor in Hashimoto's thyroiditis and spontaneous myxedema. Circulating thyroglobulin antibodies ...
Antibodies are one of the most specific tools for the detection and capture of molecular targets. The right antibody can play a key role in revealing the presence, quantity, dynamics, and even ...
End-stage organ diseases are responsible for millions of deaths worldwide each year. Organ transplantation has become the treatment of choice, but despite the 120,000 new organ transplantations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results